| A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis J Gautheron, M Vucur, F Reisinger, DV Cardenas, C Roderburg, C Koppe, ... EMBO molecular medicine 6 (8), 1062-1074, 2014 | 301 | 2014 |
| RIPK1 suppresses a TRAF2-dependent pathway to liver cancer AT Schneider, J Gautheron, M Feoktistova, C Roderburg, SH Loosen, ... Cancer cell 31 (1), 94-109, 2017 | 138 | 2017 |
| Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseases C Roderburg, F Benz, D Vargas Cardenas, A Koch, J Janssen, M Vucur, ... Liver International 35 (4), 1172-1184, 2015 | 131 | 2015 |
| microRNA 193a-5p regulates levels of nucleolar-and spindle-associated protein 1 to suppress hepatocarcinogenesis S Roy, GJ Hooiveld, M Seehawer, S Caruso, F Heinzmann, AT Schneider, ... Gastroenterology 155 (6), 1951-1966. e26, 2018 | 83 | 2018 |
| miR‐30c and miR‐193 are a part of the TGF‐β‐dependent regulatory network controlling extracellular matrix genes in liver fibrosis S Roy, F Benz, D Vargas Cardenas, M Vucur, J Gautheron, A Schneider, ... Journal of digestive diseases 16 (9), 513-524, 2015 | 83 | 2015 |
| CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma SH Loosen, C Roderburg, KL Kauertz, A Koch, M Vucur, AT Schneider, ... Scientific reports 7 (1), 16975, 2017 | 76 | 2017 |
| The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance J Gautheron, M Vucur, AT Schneider, I Severi, C Roderburg, S Roy, ... Nature Communications 7 (1), 11869, 2016 | 76 | 2016 |
| Cell-type-specific gene expression profiling in adult mouse brain reveals normal and disease-state signatures N Merienne, C Meunier, A Schneider, J Seguin, SS Nair, AB Rocher, ... Cell reports 26 (9), 2477-2493. e9, 2019 | 63 | 2019 |
| Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury S Roy, F Benz, J Alder, H Bantel, J Janssen, M Vucur, J Gautheron, ... Clinical science 130 (14), 1197-1207, 2016 | 62 | 2016 |
| miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib S Roy, H Bantel, F Wandrer, AT Schneider, J Gautheron, M Vucur, ... Journal of hepatology 67 (5), 966-978, 2017 | 50 | 2017 |
| miR-223 represents a biomarker in acute and chronic liver injury F Schueller, S Roy, SH Loosen, J Alder, C Koppe, AT Schneider, ... Clinical science 131 (15), 1971-1987, 2017 | 39 | 2017 |
| Receptor interacting protein kinase 1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity AT Schneider, J Gautheron, F Tacke, M Vucur, T Luedde Hepatology 64 (1), 306-308, 2016 | 32 | 2016 |
| Sublethal necroptosis signaling promotes inflammation and liver cancer M Vucur, A Ghallab, AT Schneider, A Adili, M Cheng, M Castoldi, ... Immunity 56 (7), 1578-1595. e8, 2023 | 26 | 2023 |
| Elevated serum levels of mixed lineage kinase domain-like protein predict survival of patients during intensive care unit treatment M Vucur, C Roderburg, L Kaiser, AT Schneider, S Roy, SH Loosen, ... Disease markers 2018, 2018 | 22 | 2018 |
| Praoperative Labordiagnostik in der Pankreaschirurgie: Was ist notwendig A Schneider, MV Singer Swiss. Surg 6 (5), 205-210, 2000 | 19 | 2000 |
| A20 promotes ripoptosome formation and TNF-induced apoptosis via cIAPs regulation and NIK stabilization in keratinocytes M Feoktistova, R Makarov, S Brenji, AT Schneider, GJ Hooiveld, T Luedde, ... Cells 9 (2), 351, 2020 | 18 | 2020 |
| Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma SH Loosen, TH Wirtz, S Roy, M Vucur, M Castoldi, AT Schneider, ... PLoS One 15 (9), e0239386, 2020 | 15 | 2020 |
| JNK signaling prevents biliary cyst formation through a CASPASE-8–dependent function of RIPK1 during aging K Müller, H Honcharova-Biletska, C Koppe, M Egger, LK Chan, ... Proceedings of the National Academy of Sciences 118 (12), e2007194118, 2021 | 13 | 2021 |
| The enigma of RIPK1 in the liver: More than just a kinase M Vucur, AT Schneider, J Gautheron, T Luedde Molecular & Cellular Oncology 4 (3), e1304191, 2017 | 10 | 2017 |
| Serum levels of soluble urokinase plasminogen activator receptor predict tumor response and outcome to immune checkpoint inhibitor therapy SH Loosen, J Gorgulho, MS Joerdens, M Schulze-Hagen, F Beier, ... Frontiers in oncology 11, 646883, 2021 | 8 | 2021 |
